via RMIT University
Researchers from RMIT University have developed a new artificial enzyme that uses light to kill bacteria.
E coli can cause dysentery and gastroenteritis, while Golden Staph is the major cause of hospital-acquired secondary infections and chronic wound infections.
Made from tiny nanorods – 1000 times smaller than the thickness of the human hair – the “NanoZymes” use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria.
Lead researcher, Professor Vipul Bansal who is an Australian Future Fellow and Director of RMIT’s Sir Ian Potter NanoBioSensing Facility, said the new NanoZymes offer a major cutting edge over nature’s ability to kill bacteria.
“For a number of years we have been attempting to develop artificial enzymes that can fight bacteria, while also offering opportunities to control bacterial infections using external ‘triggers’ and ‘stimuli’,” Bansal said. “Now we have finally cracked it.
“Our NanoZymes are artificial enzymes that combine light with moisture to cause a biochemical reaction that produces OH radicals and breaks down bacteria. Nature’s antibacterial activity does not respond to external triggers such as light.
“We have shown that when shined upon with a flash of white light, the activity of our NanoZymes increases by over 20 times, forming holes in bacterial cells and killing them efficiently.
“This next generation of nanomaterials are likely to offer new opportunities in bacteria free surfaces and controlling spread of infections in public hospitals.”
The NanoZymes work in a solution that mimics the fluid in a wound. This solution could be sprayed onto surfaces.
The NanoZymes are also produced as powders to mix with paints, ceramics and other consumer products. This could mean bacteria-free walls and surfaces in hospitals.
Public toilets — places with high levels of bacteria, and in particular E coli — are also a prime location for the NanoZymes, and the researchers believe their new technology may even have the potential to create self-cleaning toilet bowls.
A 3D rendering shows dead bacteria and where it has been eaten by the NanoZymes. Photo: Dr Chaitali Dekiwadia/ RMIT Microscopy and Microanalysis Facility
While the NanoZymes currently use visible light from torches or similar light sources, in the future they could be activated by sunlight.
The researchers have shown that the NanoZymes work in a lab environment. The team is now evaluating the long-term performance of the NanoZymes in consumer products.
“The next step will be to validate the bacteria killing and wound healing ability of these NanoZymes outside of the lab,” Bansal said.
“This NanoZyme technology has huge potential, and we are seeking interest from appropriate industries for joint product development.”
Learn more: New NanoZymes use light to kill bacteria
The Latest on: NanoZymes
via Google News
The Latest on: NanoZymes
- Cancers and heart disease could be diagnosed more easily with new rapid teston August 4, 2022 at 8:00 am
Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.
- New easy-to-use test could rapidly diagnose heart attacks and cancerson August 4, 2022 at 7:25 am
Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.
- Macrophage Delivery of Therapeutic Nanozymes in a Murine Model of Parkinson's Diseaseon July 31, 2022 at 5:01 pm
[6] To preclude BMM-mediated enzyme degradation, catalase was packaged into a block ionomer complex producing particles of nanoscale size, 'nanozymes'. The enzyme released upon stimulation of ...
- Macrophage Delivery of Therapeutic Nanozymes in a Murine Model of Parkinson's Diseaseon July 29, 2022 at 5:00 pm
Biodistribution studies suggest that nanozyme-loaded BMMs might release a portion of catalase in the blood stream, and then the nanozymes are able to reach the CNS independently of cell carriers.
- Nanotechnology newson July 28, 2022 at 5:00 pm
Microrobotic agents can form swarms of targeted drug delivery for improved imaging analyses. In a new report now published in Science Advances, Junhui Law and a team of researchers in mechanical ...
- Nanoparticle News and Researchon July 25, 2022 at 5:00 pm
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
- IISc Researchers Develop Enzymes That Can Block HIV Reactivation, Replicationon April 4, 2021 at 4:26 am
These nanozymes have been developed from vanadium pentoxide nanosheets by mimicking a natural enzyme called glutathione peroxidase that helps reduce oxidative stress levels in the host’s cells ...
via Bing News